This Biotech ETF Looks Primed To Rally Again

This Biotech ETF Looks Primed To Rally Again


The biotech sector has gotten a lot of attention lately both in the financial markets and in Washington. The sector, which was one of the worst performing areas of the market in 2016, posting a loss of more than 20%, has started posting gains again, and is looking like the rally may be poised to continue.



from Biotech News